Study details
Enrolling now
Dose Optimization of MDMA-Assisted Therapy for PTSD
Bronx VA Medical Center
NCT IDNCT06418178ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
60
Study length
about 4.4 years
Ages
18+
Locations
1 site in NY
What this study is about
This trial is testing different doses of MDMA-assisted therapy to find the best number of treatment cycles (MDMA sessions and integration sessions) for U.S. veterans with PTSD. Participants will complete one to five cycles of MDMA-AT.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Psychotherapy
- 2.Take Midomafetamine
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: PTSD Checklist for DSM-5 (PCL-5)
Secondary: Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
Body systems
Psychiatry / Mental Health